glofitamab,Obinutuzumab 
roche
['lymsm', 'dlbcl', 'glofitamab', 'cart,(-cartitude)']
#glofitamab showing good results in a difficult dlbcl #lymsm population with many post #carts, orr 50% with cr of 35% #asco22 
A hematologist @MoffittNews with interest in #lymsm. Tweets are not endorsements, and not medical advice.